anmelden
SMI Equal Weight
386,44
PKT
+2,31
PKT
+0,60
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Equal Weight-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.11.17 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 07.11.17 | Zurich Insurance Neutral | UBS AG | |
| 07.11.17 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 07.11.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 07.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.11.17 | Zurich Insurance Hold | Deutsche Bank AG | |
| 06.11.17 | Swiss Re overweight | Morgan Stanley | |
| 06.11.17 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 06.11.17 | Roche overweight | JP Morgan Chase & Co. | |
| 06.11.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 03.11.17 | UBS buy | Goldman Sachs Group Inc. | |
| 03.11.17 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 03.11.17 | UBS overweight | Morgan Stanley | |
| 03.11.17 | UBS Hold | S&P Capital IQ | |
| 03.11.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 03.11.17 | UBS kaufen | JP Morgan Chase & Co. | |
| 02.11.17 | Swiss Re kaufen | DZ BANK | |
| 02.11.17 | UBS buy | UBS AG | |
| 02.11.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 02.11.17 | Roche overweight | JP Morgan Chase & Co. | |
| 02.11.17 | UBS overweight | JP Morgan Chase & Co. | |
| 02.11.17 | Swiss Re Hold | Baader Bank | |
| 02.11.17 | Swiss Re Reduce | Commerzbank AG | |
| 01.11.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 01.11.17 | Holcim Hold | Deutsche Bank AG | |
| 01.11.17 | Holcim Neutral | UBS AG | |
| 01.11.17 | Holcim Hold | HSBC | |
| 01.11.17 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 31.10.17 | Swiss Re Sell | UBS AG | |
| 31.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 31.10.17 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 31.10.17 | Novartis buy | HSBC | |
| 31.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.10.17 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 31.10.17 | ABB (Asea Brown Boveri) Conviction Buy | Goldman Sachs Group Inc. | |
| 30.10.17 | UBS Hold | Société Générale Group S.A. (SG) | |
| 30.10.17 | UBS Sector Perform | RBC Capital Markets | |
| 30.10.17 | Holcim Underweight | Barclays Capital | |
| 30.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. |